Our company

Global Presence

The Extrovis Group is headquartered in Switzerland, operating worldwide with subsidiaries and affiliates in India, the EU, the US and Japan, focusing on creating and commercializing pharmaceutical products across the globe. We are strongly dedicated to creating value by developing and delivering quality products that make human lives better, simpler, and more convenient - through the improvement of healthcare and medicine.

VALUE PROPOSITION

We are dedicated to the development and manufacturing of niche and differentiated finished-dose pharmaceutical products. Our team of over 200 scientists and researchers focus on complex APIs and finished dosage form products. Our end-to-end delivery model is supported by a growing network of manufacturing, quality and service infrastructure globally.

All our product development work is primarily focused on meeting the regulatory/ clinical requirements of the US, the EU and/ or Japan with the possibility to leverage and requisite competitiveness also on the emerging markets.

Innovative Products

Quality assurance

Worldwide supply chain

Ethical operations

Research & development
PASSION FOR RESEARCH
Our research and development centres are focused on creating solutions to address un/undermet needs of the healthcare professionals and patients around the world by delivering differentiated products, new dosage forms and complex APIs. To keep us at the forefront of innovation in pharmaceutical process and intellectual property development, Extrovis concurrently maintains strategy and development teams in India, Japan, the EU, and the USA.
Of over 200 scientists
Our entities employ a team of over200cientists and researchers dedicated to developing our complex APIs and finished dosage form pharmaceutical products.
Collaboration + Specialization
Each of our teams specialize in different areas of expertise, with the full support and collaboration of all our other divisions, particularly our experienced Development Quality Assurance and Analytical Teams.
Cross-functional approach
We apply a cross-functional approach utilizing expertise from multiple disciplines such as analytical, engineering, quality assurance, clinical, and regulatory affairs.
Passion and professionalism
Our scientific and technical teams maintain a mindset of passion, and exceptional professionalism, matched by speed, flexibility, and a desire for value creation for stakeholders and customers worldwide.
Manufacturing
GLOBAL NETWORK AND COMPLIANCE
The Extrovis Group operates a worldwide network of state-of-the-art manufacturing facilities seamlessly integrated into the group. These facilities comply with the highest international quality standards with accreditations from the USFDA, PMDA, EU and other global regulatory bodies.
MULTIPLE DOSAGE FORMS
Our manufacturing subsidiaries are equipped with infrastructure to produce a wide range of oral, parenteral and topical dosage forms including high containment products like antibiotics, oncology and female hormonal products.
Supply continuity
Our backward integration approach combined with quality centricity and regulatory compliance at the core of the entire value chain ensures long term supply continuity.
Quality management
The Extrovis Global Quality Management System oversees the entire manufacturing process, while our alliance management function gets involved with our partners every step of the way.
Commercial
END-TO-END PRODUCT DELIVERY
We are dedicated to address the supply chain complexity of the global pharmaceutical markets by reconciling high volume, efficient manufacturing with medium to small volume order demand.
GLOBAL STABILITY AND METHOD VALIDATION CAPABILITIES
PRIMARY & SECONDARY PACKAGING INCLUDING LATE-STAGE CUSTOMIZATION OF VARIOUS DOSAGE FORMS
SERIALIZATION
IMPORTATION, RE-TESTING AND RELEASE IN THE EU AND JAPAN
REGULATORY AND PHARMACOVIGILANCE PROCEDURES
SUPPLY CHAIN CO-ORDINATION AND CUSTOMER CARE